Last Updated: Nov. 18th, 2020
Deep01(“us”, “we”, or “our”) operates http://www.deep01.com/ (the “Site”). This page informs you of our policies regarding the collection, use and disclosure of Personal Information we receive from users of the Site.
We use your Personal Information only for providing and improving the Site. By using the Site, you agree to the collection and use of information in accordance with this policy.
While using Our Service, We may ask You to provide Us with certain personally identifiable information that can be used to contact or identify You. The information might be collected in the following ways but not limited to it.
We are the sole owners of the information collected on the Site. We will not sell or rent this information to anyone. We will use your information to respond to you, regarding the reason you contacted us. We will not share your information with any third party outside of our organization, other than as necessary to fulfill your request. We may use Personal Data for the following purposes:
The security of Your Personal Data is important to Us. However, no method of transmission over the Internet, or method of electronic storage is 100% secure. While We strive to use commercially acceptable means to protect Your Personal Data, We cannot guarantee its absolute security.
Innovative, Comprehensive, and Effective
Deep01, a Taiwan-based software startup that develops AI-based solutions for intracranial hemorrhage detection which can be applied in hospitals to improving workflow, has received several validations in the world.
In July of 2019, Deep01 obtained its first FDA, which is the first deep learning US FDA in Asia Pacific. The good start is continued by the approval of FDA of Taiwan and Thailand which was obtained in the February and September of 2020.
The approval of Deep01 in its home country is also significant since it is the first Taiwan FDA using deep learning technology. The latest validation is CE mark which was received in Feb. 2021, accumulating a total of 4 validation in the world. With its achievement of regulatory clearance within one and a half year, Deep01 is optimistic of the development of global market.